Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort study

BACKGROUND: Emerging laboratory and animal studies suggest that aspirin may prevent non-alcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC), however clinical evidence remains lacking. METHODS: Using Taiwan’s National Health Insurance Research Database, we screened 145,212 NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Teng-Yu, Hsu, Yao-Chun, Ho, Hsiu J., Lin, Jaw-Town, Chen, Yi-Ju, Wu, Chun-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331813/
https://www.ncbi.nlm.nih.gov/pubmed/37434747
http://dx.doi.org/10.1016/j.eclinm.2023.102065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331813/
https://www.ncbi.nlm.nih.gov/pubmed/37434747
http://dx.doi.org/10.1016/j.eclinm.2023.102065

Ejemplares similares